UniSuper Management Pty Ltd Purchases 6,496 Shares of Elevance Health, Inc. $ELV

UniSuper Management Pty Ltd raised its position in shares of Elevance Health, Inc. (NYSE:ELV) by 40.8% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 22,421 shares of the company’s stock after purchasing an additional 6,496 shares during the quarter. UniSuper Management Pty Ltd’s holdings in Elevance Health were worth $7,245,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. Canoe Financial LP raised its stake in shares of Elevance Health by 18.1% in the third quarter. Canoe Financial LP now owns 389,399 shares of the company’s stock worth $125,823,000 after buying an additional 59,743 shares during the period. Synergy Asset Management LLC raised its stake in Elevance Health by 100.0% during the 3rd quarter. Synergy Asset Management LLC now owns 104,334 shares of the company’s stock worth $33,712,000 after acquiring an additional 52,167 shares during the period. Delta Investment Management LLC purchased a new position in Elevance Health during the third quarter valued at approximately $7,629,000. OLD National Bancorp IN boosted its position in shares of Elevance Health by 44.8% in the second quarter. OLD National Bancorp IN now owns 6,267 shares of the company’s stock worth $2,438,000 after purchasing an additional 1,939 shares during the period. Finally, Verdence Capital Advisors LLC increased its stake in shares of Elevance Health by 3.9% in the second quarter. Verdence Capital Advisors LLC now owns 21,213 shares of the company’s stock worth $8,251,000 after purchasing an additional 790 shares in the last quarter. Institutional investors own 89.24% of the company’s stock.

Elevance Health Trading Down 0.4%

Shares of Elevance Health stock opened at $370.77 on Friday. Elevance Health, Inc. has a twelve month low of $273.71 and a twelve month high of $458.75. The company has a quick ratio of 1.56, a current ratio of 1.56 and a debt-to-equity ratio of 0.71. The business has a 50-day moving average price of $349.17 and a 200-day moving average price of $328.79. The firm has a market cap of $82.40 billion, a price-to-earnings ratio of 15.16, a PEG ratio of 1.91 and a beta of 0.51.

Analyst Upgrades and Downgrades

ELV has been the topic of a number of analyst reports. Robert W. Baird lifted their target price on shares of Elevance Health from $297.00 to $340.00 and gave the company a “neutral” rating in a research note on Thursday, December 11th. Sanford C. Bernstein reiterated an “outperform” rating and issued a $431.00 price target on shares of Elevance Health in a research note on Tuesday, January 6th. Wall Street Zen downgraded Elevance Health from a “buy” rating to a “hold” rating in a research report on Saturday, December 13th. Bank of America increased their target price on Elevance Health from $330.00 to $370.00 and gave the stock a “neutral” rating in a research report on Friday, October 10th. Finally, TD Cowen reissued a “buy” rating on shares of Elevance Health in a research note on Wednesday, November 26th. Twelve equities research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $399.63.

Elevance Health Profile

Elevance Health, Inc (NYSE: ELV) is a large U.S.-based health benefits company that provides a broad range of health insurance products and related services. Headquartered in Indianapolis, the company rebranded from Anthem, Inc to Elevance Health in 2022 while continuing to operate consumer-facing health plans under established state and national brands. Gail Boudreaux serves as chief executive officer and president, leading the company’s strategic focus on integrated health care and benefit delivery.

Elevance’s core activities include offering medical and specialty health plans for individuals, employers and government programs, including Medicare and Medicaid managed-care products.